Hohimer Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.07M Buy
1,788
+27
+2% +$31.9K 0.2% 129
2026
Q2
$2.11M Sell
1,761
-38
-2% -$38.8K 0.21% 132
2026
Q1
$1.65M Sell
1,799
-180
-9% -$182K 0.2% 132
2025
Q4
$2.13M Buy
1,979
+102
+5% +$97.5K 0.29% 105
2025
Q3
$1.43M Buy
1,877
+358
+24% +$266K 0.2% 122
2025
Q2
$1.18M Buy
1,519
+76
+5% +$59.1K 0.21% 101
2025
Q1
$1.19M Buy
1,443
+719
+99% +$598K 0.23% 99
2024
Q4
$559K Buy
724
+308
+74% +$255K 0.11% 140
2024
Q3
$369K Sell
416
-14
-3% -$12.6K 0.08% 153
2024
Q2
$389K Sell
430
-22
-5% -$17.6K 0.09% 164
2024
Q1
$352K Hold
452
– – 0.08% 182
2023
Q4
$263K Buy
452
+11
+2% +$6.42K 0.07% 176
2023
Q3
$237K Sell
441
-11
-2% -$5.67K 0.07% 175
2023
Q2
$212K Buy
+452
New +$190K 0.06% 177

Other funds holding LLY

Hohimer Wealth Management's LLY Position: Q3 2026 in Review

Hohimer Wealth Management increased its Eli Lilly (LLY) stake by 1.5% in Q3 2026, buying an estimated $31.9K and bringing the position to 1,788 shares worth $2.07M. The position accounts for 0.2% of the portfolio, ranked #129.

Hohimer Wealth Management first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $2.13M in Q4 2025. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Hohimer Wealth Management held 1,788 shares of Eli Lilly worth $2.07M as of Q3 2026.
  • Hohimer Wealth Management bought 27 Eli Lilly shares in Q3 2026, an estimated $31.9K.
  • Eli Lilly made up 0.2% of Hohimer Wealth Management's portfolio in Q3 2026, its #129 holding.
  • Hohimer Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
  • Hohimer Wealth Management's Eli Lilly position peaked at $2.13M in Q4 2025.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Hohimer Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.